Madrigal Pharmaceuticals, Inc. (MDGL)

610.11 +7.90 (+1.31%) USD  |  NASDAQ  |  Dec 24, 12:01
More

Madrigal Pharmaceuticals Return on Invested Capital (3y Median)

Return on Invested Capital (3y Median) Chart

View Return on Invested Capital (3y Median) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Invested Capital (3y Median) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Invested Capital (3y Median) Range, Past 5 Years

View Return on Invested Capital (3y Median) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Invested Capital (3y Median) Benchmarks

View Return on Invested Capital (3y Median) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade